title: Innovations in the treatment of melanoma.
authors.affiliation: New York University School of Medicine, New York, New York 10016, USA. anna.pavlick@msnyuhealth.org
authors.forename: Anna C
authors.initials: AC
authors.lastname: Pavlick
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D019496:Cancer Vaccines / Q000627:therapeutic use*; D016373:DNA, Antisense; D015316:Genetic Therapy; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008545:Melanoma / Q000628:therapy*; D009536:Niacinamide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010671:Phenylurea Compounds / Q000627:therapeutic use*; D061988:Proteasome Inhibitors / Q000627:therapeutic use; D000077157:Sorafenib
chemical_list: D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D019496:Cancer Vaccines; D016373:DNA, Antisense; D007155:Immunologic Factors; D010671:Phenylurea Compounds; D061988:Proteasome Inhibitors; D009536:Niacinamide; D000077157:Sorafenib